OBJECTIVE: To identify early cognitive and neuroimaging features of sporadic nonfluent/agrammatic variant of primary progressive aphasia (nfvPPA) caused by frontotemporal lobar degeneration (FTLD) subtypes. METHODS: We prospectively collected clinical, neuroimaging, and neuropathologic data in 11 patients with sporadic nfvPPA with FTLD-tau (nfvPPA-tau, n = 9) or FTLD-transactive response DNA binding protein pathology of 43 kD type A (nfvPPA-TDP, n = 2). We analyzed patterns of cognitive and gray matter (GM) and white matter (WM) atrophy at presentation in the whole group and in each pathologic subtype separately. We also considered longitudinal clinical data. RESULTS: At first evaluation, regardless of pathologic FTLD subtype, apraxia of speech (AOS) was the most common cognitive feature and atrophy involved the left posterior frontal lobe. Each pathologic subtype showed few distinctive features. At presentation, patients with nfvPPA-tau presented with mild to moderate AOS, mixed dysarthria with prominent hypokinetic features, clear agrammatism, and atrophy in the GM of the left posterior frontal regions and in left frontal WM. While speech and language deficits were prominent early, within 3 years of symptom onset, all patients with nfvPPA-tau developed significant extrapyramidal motor signs. At presentation, patients with nfvPPA-TDP had severe AOS, dysarthria with spastic features, mild agrammatism, and atrophy in left posterior frontal GM only. Selective mutism occurred early, when general neurologic examination only showed mild decrease in finger dexterity in the right hand. CONCLUSIONS: Clinical features in sporadic nfvPPA caused by FTLD subtypes relate to neurodegeneration of GM and WM in frontal motor speech and language networks. We propose that early WM atrophy in nfvPPA is suggestive of FTLD-tau pathology while early selective GM loss might be indicative of FTLD-TDP.
OBJECTIVE: To identify early cognitive and neuroimaging features of sporadic nonfluent/agrammatic variant of primary progressive aphasia (nfvPPA) caused by frontotemporal lobar degeneration (FTLD) subtypes. METHODS: We prospectively collected clinical, neuroimaging, and neuropathologic data in 11 patients with sporadic nfvPPA with FTLD-tau (nfvPPA-tau, n = 9) or FTLD-transactive response DNA binding protein pathology of 43 kD type A (nfvPPA-TDP, n = 2). We analyzed patterns of cognitive and gray matter (GM) and white matter (WM) atrophy at presentation in the whole group and in each pathologic subtype separately. We also considered longitudinal clinical data. RESULTS: At first evaluation, regardless of pathologic FTLD subtype, apraxia of speech (AOS) was the most common cognitive feature and atrophy involved the left posterior frontal lobe. Each pathologic subtype showed few distinctive features. At presentation, patients with nfvPPA-tau presented with mild to moderate AOS, mixed dysarthria with prominent hypokinetic features, clear agrammatism, and atrophy in the GM of the left posterior frontal regions and in left frontal WM. While speech and language deficits were prominent early, within 3 years of symptom onset, all patients with nfvPPA-tau developed significant extrapyramidal motor signs. At presentation, patients with nfvPPA-TDP had severe AOS, dysarthria with spastic features, mild agrammatism, and atrophy in left posterior frontal GM only. Selective mutism occurred early, when general neurologic examination only showed mild decrease in finger dexterity in the right hand. CONCLUSIONS: Clinical features in sporadic nfvPPA caused by FTLD subtypes relate to neurodegeneration of GM and WM in frontal motor speech and language networks. We propose that early WM atrophy in nfvPPA is suggestive of FTLD-tau pathology while early selective GM loss might be indicative of FTLD-TDP.
Authors: Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee Journal: Science Date: 2006-10-06 Impact factor: 47.728
Authors: Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen Journal: Brain Date: 2006-04-13 Impact factor: 13.501
Authors: Jennifer M Ogar; Nina F Dronkers; Simona M Brambati; Bruce L Miller; Maria Luisa Gorno-Tempini Journal: Alzheimer Dis Assoc Disord Date: 2007 Oct-Dec Impact factor: 2.703
Authors: E J Kim; G D Rabinovici; W W Seeley; C Halabi; H Shu; M W Weiner; S J DeArmond; J Q Trojanowski; M L Gorno-Tempini; B L Miller; H J Rosen Journal: J Neurol Neurosurg Psychiatry Date: 2007-07-05 Impact factor: 10.154
Authors: William W Seeley; Brandy R Matthews; Richard K Crawford; Maria Luisa Gorno-Tempini; Dean Foti; Ian R Mackenzie; Bruce L Miller Journal: Brain Date: 2007-12-05 Impact factor: 13.501
Authors: Ian R A Mackenzie; Atik Baborie; Stuart Pickering-Brown; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; David Neary; Julie S Snowden; David M A Mann Journal: Acta Neuropathol Date: 2006-09-26 Impact factor: 17.088
Authors: Maya L Henry; H Isabel Hubbard; Stephanie M Grasso; Heather R Dial; Pélagie M Beeson; Bruce L Miller; Maria Luisa Gorno-Tempini Journal: J Speech Lang Hear Res Date: 2019-08-07 Impact factor: 2.297
Authors: Maria Luisa Mandelli; Eduard Vilaplana; Jesse A Brown; H Isabel Hubbard; Richard J Binney; Suneth Attygalle; Miguel A Santos-Santos; Zachary A Miller; Mikhail Pakvasa; Maya L Henry; Howard J Rosen; Roland G Henry; Gil D Rabinovici; Bruce L Miller; William W Seeley; Maria Luisa Gorno-Tempini Journal: Brain Date: 2016-08-06 Impact factor: 13.501
Authors: Borna Bonakdarpour; Robert S Hurley; Allan R Wang; Hernando R Fereira; Anisha Basu; Arjuna Chatrathi; Kyla Guillaume; Emily J Rogalski; M Marsel Mesulam Journal: Cortex Date: 2019-09-09 Impact factor: 4.027
Authors: Edoardo G Spinelli; Maria Luisa Mandelli; Zachary A Miller; Miguel A Santos-Santos; Stephen M Wilson; Federica Agosta; Lea T Grinberg; Eric J Huang; John Q Trojanowski; Marita Meyer; Maya L Henry; Giancarlo Comi; Gil Rabinovici; Howard J Rosen; Massimo Filippi; Bruce L Miller; William W Seeley; Maria Luisa Gorno-Tempini Journal: Ann Neurol Date: 2017-03-20 Impact factor: 10.422
Authors: Maria Luisa Mandelli; Eduardo Caverzasi; Richard J Binney; Maya L Henry; Iryna Lobach; Nikolas Block; Bagrat Amirbekian; Nina Dronkers; Bruce L Miller; Roland G Henry; Maria Luisa Gorno-Tempini Journal: J Neurosci Date: 2014-07-16 Impact factor: 6.167
Authors: Miguel A Santos-Santos; Maria Luisa Mandelli; Richard J Binney; Jennifer Ogar; Stephen M Wilson; Maya L Henry; H Isabel Hubbard; Minerva Meese; Suneth Attygalle; Lynne Rosenberg; Mikhail Pakvasa; John Q Trojanowski; Lea T Grinberg; Howie Rosen; Adam L Boxer; Bruce L Miller; William W Seeley; Maria Luisa Gorno-Tempini Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302